Publikationen in Zusammenarbeit mit Forschern von University Hospital of Geneva (9)

2019

  1. Correction to: T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway (Cellular and Molecular Immunology, (2017), 14, 6, (497-510), 10.1038/cmi.2015.101)

    Cellular and Molecular Immunology

2018

  1. Therapeutic implications of NK cell regulation of allogeneic CD8 T cell-mediated immune responses stimulated through the direct pathway of antigen presentation in transplantation

    mAbs, Vol. 10, Núm. 7, pp. 1030-1044

2017

  1. Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier

    Translational Research, Vol. 181, pp. 83-95.e3

  2. T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway

    Cellular and Molecular Immunology, Vol. 14, Núm. 6, pp. 497-510

2013

  1. ITIM-dependent negative signaling pathways for the control of cell-mediated xenogeneic immune responses

    Xenotransplantation, Vol. 20, Núm. 6, pp. 397-406

2012

  1. Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction

    Journal of Immunology, Vol. 188, Núm. 10, pp. 4885-4896

2010

  1. HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation

    Journal of Leukocyte Biology, Vol. 87, Núm. 2, pp. 223-235

2008

  1. PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation

    Transplant International, Vol. 21, Núm. 11, pp. 1015-1028

2007

  1. Blockade of the PD-1/PD-1L pathway reverses the protective effect of anti-CD40L therapy in a rat to mouse concordant islet xenotransplantation model

    Xenotransplantation, Vol. 14, Núm. 3, pp. 243-248